5-112843215-A-G
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_000038.6(APC):āc.7621A>Gā(p.Ile2541Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000899 in 1,613,724 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000038.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
APC | NM_000038.6 | c.7621A>G | p.Ile2541Val | missense_variant | 16/16 | ENST00000257430.9 | NP_000029.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
APC | ENST00000257430.9 | c.7621A>G | p.Ile2541Val | missense_variant | 16/16 | 5 | NM_000038.6 | ENSP00000257430 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152192Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000108 AC: 27AN: 250678Hom.: 0 AF XY: 0.0000960 AC XY: 13AN XY: 135430
GnomAD4 exome AF: 0.0000876 AC: 128AN: 1461532Hom.: 0 Cov.: 34 AF XY: 0.0000811 AC XY: 59AN XY: 727076
GnomAD4 genome AF: 0.000112 AC: 17AN: 152192Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74356
ClinVar
Submissions by phenotype
not provided Uncertain:4
Uncertain significance, no assertion criteria provided | clinical testing | Department of Pathology and Laboratory Medicine, Sinai Health System | - | The APC p.Ile2541Val variant was identified in 1 of 1382 proband chromosomes (frequency: 0.0007) from individuals or families with colorectal adenomas and was present in 1 of 3300 control chromosomes (frequency: 0.0003) from healthy individuals (Azzopardi 2008, Bodian 2014). The variant was also identified in dbSNP (ID: rs587778033) as "With Uncertain significance allele", ClinVar (classified as likely benign by Color and Ambry Genetics; as uncertain significance by Invitae, GeneDx and three other submitters), and UMD-LSDB (2x as neutral). The variant was not identified in LOVD 3.0 . The variant was identified in control databases in 26 of 276400 chromosomes at a frequency of 0.00009 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: African in 3 of 24028 chromosomes (freq: 0.0001), Other in 1 of 6448 chromosomes (freq: 0.0002), Latino in 2 of 34396 chromosomes (freq: 0.00006), European in 13 of 125980 chromosomes (freq: 0.0001), Ashkenazi Jewish in 1 of 10126 chromosomes (freq: 0.0001), and South Asian in 6 of 30780 chromosomes (freq: 0.0002), while the variant was not observed in the East Asian, and European , populations. The p.Ile2541 residue is not conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein; however, this information is not predictive enough to rule out pathogenicity. The variant occurs outside of the splicing consensus sequence and 2 of 4 in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) predict a greater than 10% difference in splicing; this is not very predictive of pathogenicity. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Oct 19, 2023 | In silico analysis supports that this missense variant does not alter protein structure/function; Observed in an individual with multiple colorectal adenomas (Azzopardi et al., 2008); This variant is associated with the following publications: (PMID: 26373574, 21859464, 24728327, 24599579, 30836094, 34378333, 18199528) - |
Uncertain significance, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 05, 2017 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Oct 06, 2021 | The p.Ile2541Val variant in APC has been reported in 1 individual with multiple colorectal adenomas (Azzopardi 2008 PMID: 18199528), but has also been identified in a healthy adult (Bodian 2014 PMID: 24728327) and in 0.02% (6/30614) of South Asian chromosomes by gnomAD (http://gnomad.broadinstitute.org). Isoleucine (Ile) at position 2541 is not well conserved: Four mammals (Chinese tree shrew, rabbit, pika, and star-nosed mole) carry a valine (Val) at this position despite high nearby amino acid conservation, suggesting that this change may be tolerated. Finally, this variant has been reported in ClinVar with conflicting interpretations (Likely Benign and Variant of Uncertain Significance; Variation ID# 133514). In summary, while the clinical significance of the p.Ile2541Val variant is uncertain, these data suggest that it is more likely to be benign. The ACMG/AMP Criteria applied: BP4. - |
Hereditary cancer-predisposing syndrome Uncertain:1Benign:2
Uncertain significance, criteria provided, single submitter | curation | Sema4, Sema4 | Oct 29, 2021 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 08, 2018 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Likely benign, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | Jun 14, 2016 | - - |
not specified Benign:2Other:1
Likely benign, criteria provided, single submitter | clinical testing | Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital | Jul 31, 2024 | - - |
not provided, no classification provided | reference population | ITMI | Sep 19, 2013 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jun 28, 2024 | Variant summary: APC c.7621A>G (p.Ile2541Val) results in a conservative amino acid change located in the basic domain (IPR009234) of the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00011 in 252814 control chromosomes (gnomAD). The observed variant frequency is approximately 1.5-fold of the estimated maximal expected allele frequency for a pathogenic variant in APC causing Familial Adenomatous Polyposis phenotype (7.1e-05). c.7621A>G has been reported in the literature in individuals affected with Familial Adenomatous Polyposis (Azzopardi_2008), however no supportive evidence was provided for causality, in addition, the variant has also been reported in healthy controls (Bodian_2014). These reports do not provide unequivocal conclusions about association of the variant with Familial Adenomatous Polyposis. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 24728327, 18199528, 24599579, NO_PMID, 25882375). ClinVar contains an entry for this variant (Variation ID: 133514). Based on the evidence outlined above, the variant was classified as likely benign. - |
Familial adenomatous polyposis 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at